Eva Nilsagård
Chairman of the board
Board member since: 2020
Born: 1964
Main occupation: Board professional
Holdings in Spermosens
Shares: 102 000
Options: 72 000
Eva Nilsagård is currently the founder and CEO of Nilsagård Consulting AB. Eva holds an executive MBA in business management and organization as well as a master’s degree in accounting and finance from the Gothenburg School of Economics. Eva has been CFO at OptiGroup, Vitrolife and Plastal, SVP Strategy & Business development at Volvo Group and held senior positions in finance and business development at Volvo, AstraZeneca and SKF. Eva has a long experience of listed companies and over 10 years of experience as a mentor for young female managers.
Other current assignments: Chairman of the board of Diagonal Bio AB. Board member and chairman of the audit committee in Nimbus Group AB, Hansa Biopharma AB, Xbrane Biopharma AB, Aktiebolaget Svensk Exportkredit (Swedish Export Credit corporation), IRRAS AB, Addlife AB, Bufab AB, Nanexa AB, and board member of Ernströmgruppen and eEducation Albert AB. Nilsagård Consulting AB, Chairman of the board and CEO.
Independent in relation to the company and company management and in relation to the company’s major shareholders.
Ingela Liljeqvist Soltic
Board member
Board member since: 2019
Born: 1967
Main occupation: Embryologist and Unit Manager, Laboratory, Reproductive Medicine Centre, Skåne University Hospital
Holdings in Spermosens
–
Dr. Ingela Liljeqvist Soltic currently works as an embryologist and unit manager for laboratory and tissue establishment at the Center for Reproductive Medicine (RMC) at Skåne University Hospital. Ingela has a BSc in Biomedical Laboratory Technology from Lund University and a PhD in Biomedical Science.Ingela has previously worked as an embryologist at IVF Clinic Cura Öresund and at the pharmaceutical company Merck. Ingela has extensive experience from IVF and fertility issues.
Independent in relation to the company and company management and in relation to the company’s major shareholders.
Christina Östberg-Lloyd
Board member
Board member since: 2022
Main occupation: Senior Vice President och Global Head, Reproductive Medicine Maternal Health, RMMH, Ferring Pharmaceuticals A/S.
Holdings in Spermosens
–
Christina Östberg Lloyd currently holds a globally leading position at Ferring Pharmaceuticals A / S as Senior Vice President and Global Head, Reproductive Medicine Maternal Health, RMMH. Christina is M.D. and specializes in gynecology and obstetrics with a focus on reproductive medicine, regarding both male and female infertility.
Other current assignments: Part owner of Care & Communication AB, Senior medical advisor Pharmiva AB.
Independent in relation to the company and company management and in relation to the company’s major shareholders.
Sören Melsing Frederiksen
Board member
Board member since: 2020
Born: 1976
Main occupation: VP Product Development & Commercial Rx, Orifarm Healthcare
Holdings in Spermosens (through company and privately)
Shares: 395 132
Options: 175 000
Sören Melsing Frederiksen currently holds the position of Vice President, Product Development and Commercial Rx, ORIFARM GROUP A/S. Søren holds a B.A.Sc in Applied Science and a master’s degree in drug development. Previsouly, Søren held a position as VP Sales & Marketing in Galenica AB and before that held several positions within LEO Pharma and a role in Aspen Pharma Nordic. Søren has extensive experience in marketing and sales as well as the entire value chain in the pharmaceutical industry.
Other current assignments: VBM Ejendomsselskabet af 2007 Aps, board member. StenoCare A/S, board member. SML Holding ApS, board member and CEO.
Independent in relation to the company and company management and in relation to the company’s major shareholders.
Kushagr Punyani
Board member
Board member since: 2018
Born: 1991
Main occupation: CEO, Nested Bio AB
Holdings in Spermosens (through company and privately)
Shares: 1 637 764
Options: 59 524
Kushagr Punyani is founder and CSO for Spermosens AB. Kushagr holds a licentiate degree in engineering, microfluidic technology, from Lund University. From his studies in India together with Professor Sudha Srivastava, Punyani laid the foundation for Spermosens’ technology. Kushagr has also been involved in founding a number of companies that develop new technologies in medtech / pharmaceuticals.
Other current assignments: Prolevi Bio AB, Chairman of the board. Diagonal Pharma AB, board member. Nested Bio AB, board member.
Member of company management and major shareholder.
